Proposed Directors of Tirupati Graphite explain why they have requisitioned an GM. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksYGEN.L Regulatory News (YGEN)

  • There is currently no data for YGEN

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Technology Update

5 Jun 2007 15:00

ViaLogy PLC05 June 2007 ViaLogy Announces IPv6-capable MicroSPM(TM)for High Definition SurveillanceVideo Processing LONDON, June 5, 2007 -- ViaLogy plc (LSE: VIY), announced today that it hasdeveloped IPv6-capable MicroSPM(TM), compact embedded hardware for highdefinition video processing applications over IP-converged networks. MicroSPM(TM)extends ViaLogy's SPM(TM)software product family by delivering anetwork-centric hardware policy-engine for fully-autonomous incident-based rapiddetection, analysis and response. The MicroSPM(TM)platform addresses threemajor trends within the global surveillance industry: increasing adoption ofnetwork addressable digital video camera and thermal imagers; need for real-timeautonomous processing by moving the policy and the intelligence to the networkedge, and, the accelerated migration to IPv6 addressing standards. MicroSPM(TM)is powered by ViaLogy's proprietary, patented signal processingQuantum Resonance Interferometry ("QRI") technology for detecting weak signalsand image features in high background clutter. QRI delivers video-applicationsin the form of prepackaged user customizable policies in firmware. Initialapplications include: face-extraction in crowds; human, object and vehicledetection and counting, and license plate reading. Immediate verticals includedefense, oil & gas, enterprise safety and security, and, perimeter and bordersurveillance. MicroSPM(TM)enables high speed processing at the video source,only transmitting policy-based exceptions and events to the operator sites. Italso delivers plug-and-play interoperability for IP-enabled video and night-vision devices from different vendors. Today, video surveillance systems are an essential remote monitoring tool forcritical infrastructure, including airports, border crossings, ports, dams,trains and subways; financial and governmental institutions; power grids,utilities and refining facilities. Video is routinely used by businesses formonitoring entrances, walkways, parking lots and warehouses. In banks andretail, surveillance cameras are strategically positioned to monitor and recordthe behavior of customers and tellers. However, the bulk of decision making isperformed by human operators staring at multiple video consoles and manuallycontrolling cameras. Size of this overall video surveillance market is estimatedat over $3 billion for 2007, with sales of security cameras exceeding 6 millionunits and growing at over 30%. According to ViaLogy CTO, Dr. Sandeep Gulati, "Centralized operator-based videoviewing and security decision making is a major choke-point in timely response.Bulk of video is archived and only used for post-incident analysis. MicroSPM'real-time edge processing will significantly expand the actionable informationbandwidth for customers. This is consistent with our focus on broad marketapplications where ViaLogy's QRI signal processing becomes an enabler." ViaLogy President and CEO, Mr. Shah Talukder stated "Customers are facingsignificant challenges in managing a multitude of sensor, video and otherdevices in their networked environments. We see a significant opportunity forscaleable, cost effective and future-proof solutions to manage their global andregional security networks." He added, "We also see MicroSPM(TM)enablingpartners to IPv6-enable their fixed and mobile sensors and network subsystems". Vialogy is in discussions with customers and partners to pilot and deployMicroSPM(TM)within their surveillance infrastructure. For further information please contact: ViaLogyShah Talukder, President & CEO - US +1 626-296-6337Terry Bond, Chairman - UK & Europe +44 (0)20 2869 7014 Redleaf CommunicationsSamantha Robbins / Anna Dunkin +44 (0)20 7822 0200 About ViaLogy: Network Centric Signal Processing. ViaLogy is a leading innovator of network-centric, real-time signal processingplatforms for sensor applications. ViaLogy is currently deploying and designingcomputational systems, powered by its patented technologies, for applications inlife sciences, public safety and security, surveillance, defense andgeoseismology. Vialogy focuses on market driven problems where automation,timeliness, quality and reliability of information processing are essential.ViaLogy's core competency incorporates rapidly and accurately detecting weaksignals buried in high noise background and clutter. This technology can beemployed to solve problems involving sensor integration and information overloadchallenges involving video, telephony and control sensors, as well as forenhancement of numerous signal processing applications. For more information,visit our website at www.vialogy.com. Except for statements of historical fact, the information presented hereinconstitutes forward-looking statements within the meaning of the PrivateSecurities Litigation Reform Act of 1995. Such forward-looking statementsinvolve known and unknown risks, uncertainties and other factors which may causethe actual results, performance or achievements of the company to be materiallydifferent from any future results, performance or achievements expressed orimplied. This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
7th Feb 20177:00 amRNSSouthern Europe Business Update
10th Jan 20173:33 pmRNSResult of General Meeting
10th Jan 20177:15 amRNSHardman Research: Yourgene improves growth
21st Dec 20164:00 pmRNSPosting of Circular
21st Dec 20167:00 amRNSHalf year results
21st Dec 20167:00 amRNSConditional Acquisition of Yourgene Bioscience
21st Nov 20167:00 amRNSPremaitha establishes first service lab in Asia
31st Oct 20167:00 amRNSPremaitha welcomes UK Govt. decision on NIPT
27th Oct 20164:10 pmRNSResult of AGM
27th Oct 20167:00 amRNSAGM Statement
21st Oct 20167:00 amRNSGrant of Options
3rd Oct 20167:15 amRNSHardman Research: Excellent first year for IONA®
30th Sep 20163:38 pmRNSNotice of AGM
30th Sep 20167:00 amRNSFinal Results
23rd Sep 201610:42 amRNSHolding(s) in Company
23rd Sep 20168:50 amRNSNotice of results & appointment of broker
23rd Sep 20168:50 amRNSInvestment agreement extension with Thermo Fisher
8th Sep 20169:08 amRNSDirectorate Change
6th Jul 20167:00 amRNSDirectorate Change
4th Jul 20167:00 amRNSProgress on anti-trust objections to litigation
22nd Jun 20167:00 amRNSAdoption of Financial Reporting Standard (FRS) 101
22nd Apr 201610:45 amRNSUpdate on competitor patent litigation
20th Apr 201611:14 amRNSHardman Research: IONA sales & litigation update
20th Apr 20167:00 amRNSPatent Litigation Rescheduled
18th Apr 20161:13 pmRNSHardman & Co Issues Research Report
18th Apr 20161:03 pmRNSHardman & Co Issues Research Report
14th Apr 20167:00 amRNSHolding(s) in Company
13th Apr 20169:52 amRNSHolding(s) in Company
13th Apr 20167:00 amRNSHoldings in Company, Director's Shareholding
11th Apr 20167:00 amRNSTrading Update
29th Mar 20167:00 amRNSPremaitha announces tenth customer laboratory
21st Mar 20167:00 amRNSDistribution Agreements in the Middle East
9th Mar 20165:21 pmRNSHolding in Company, Directors' Dealing Replacement
9th Mar 20163:33 pmRNSHolding in Company, Directors' Dealings
9th Mar 20167:00 amRNSDistribution Agreement with GeNext - Russia
7th Mar 20167:00 amRNSAppointment of Joint Broker
3rd Feb 20167:00 amRNSPremaitha partners with Visional Medical in India
2nd Feb 20167:00 amRNSPremaitha partners with Leeds Hospitals NHS Trust
28th Jan 20167:00 amRNSHardman & Co Research Report: IONA®-Up and running
27th Jan 20167:00 amRNSTwo new customers signed for clinical lab service
26th Jan 20162:29 pmRNSUpdate on UK Litigation Timing
15th Jan 20167:00 amRNSPremaitha welcomes NSC recommendation on NIPT
8th Jan 201612:40 pmRNSUpdate on competitor patent litigation
18th Dec 20157:00 amRNSDirector/PDMR Shareholding
16th Dec 20155:53 pmRNSHolding(s) in Company
15th Dec 20157:00 amRNSHardman Issues Research Report
14th Dec 20157:00 amRNSInvestment Agreement with Thermo Fisher Scientific
14th Dec 20157:00 amRNSHalf Yearly Report
11th Dec 20157:00 amRNSNotice of Half Year Results
2nd Dec 20157:00 amRNSFirst IONA® testing service in France at LaboSud

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.